CD55 antibody (FITC)
Quick Overview for CD55 antibody (FITC) (ABIN3071832)
Target
See all CD55 AntibodiesReactivity
Host
Clonality
Conjugate
Application
Grade
Clone
-
-
Purpose
- CD55 FITC Antibody
-
Characteristics
- The clone F4-29D9 binds with a single chain 70 kDa glycoprotein and identified as CD55 (also known as decay accelerating factor, DAF). CD55 is widely expressed on cells throughout the body including leukocytes, erythrocytes, epithelium, endothelium, and fibroblasts. It is a Glycosyl phosphatidylinositol anchored (GPI-anchored) protein and inhibits autologous complement cascade activation. CD55 also serves as receptor for CD97, echovirus and Coxsackie B virus. Anticd55 is a useful marker for the diagnosis of paroxysmal nocturnal hemoglobinuria (PNH).
-
Purification
- Purified
-
Purity
- >95 %
-
Immunogen
- Human umbilical vein endothelial cells (HUVEC)
-
Isotype
- IgG1, kappa
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 50 μg/mL
-
Buffer
- PBS pH 7.2, 0.2 % (w/v) BSA, 0.09 % (w/v) sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- 4 °C
-
Storage Comment
- 2-8°C, Conjugated antibodies should never be frozen.
-
-
- CD55 (Complement Decay-Accelerating Factor (CD55))
-
Alternative Name
- CD55
-
NCBI Accession
- NP_000565, NM_000574, NP_001108224, NM_001114752, NP_001287832, NM_001300903, NP_001287833
-
UniProt
- P08174
-
Pathways
- Complement System, Regulation of Leukocyte Mediated Immunity
Target
-